Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
07/2012
07/03/2012US8211910 Tri-, tetra-substituted-3-aminopyrrolidine derivative
06/2012
06/28/2012WO2012087372A1 Fungicidal 2-(bicyclic aryloxy)carboxamides
06/28/2012WO2012083866A1 Quinoline derivatives as anti-cancer agents
06/28/2012US20120165535 Synthetic method for montelukast sodium intermediate
06/28/2012US20120165534 Process for preparing bromo-substituted quinolines
06/28/2012US20120165372 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
06/28/2012US20120165370 Quinoline derivatives as anti-cancer agents
06/28/2012US20120165369 3-SUBSTITUTED QUINOLINIUM AND 7H-INDOLO[2,3-c]QUINOLINIUM SALTS AS NEW ANTIINFECTIVES
06/28/2012CA2845524A1 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
06/27/2012EP2468281A1 Quinoline derivative-containing pharmaceutical composition
06/27/2012EP2467364A2 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
06/27/2012EP2467361A1 Novel quinoline-hepcidine antagonists
06/27/2012EP1636190B1 Stable crystal of 4-oxoquinoline compound
06/27/2012EP1389611B1 20-hydroxyeicosatetraenoic acid production inhibitors
06/27/2012EP1221434B1 Hydrocarbon compound, material for organic electroluminescent element and organic electroluminescent element
06/27/2012CN102516168A Ciprofluoroquinolone C3/C7 dithizone Schiff base, preparation method and application thereof
06/27/2012CN102516167A Synthesis method of quinolone compound
06/27/2012CN102260210B Preparation method of naphthoyl amine derivatives of protein kinase inhibitor and histone deacetylase inhibitor
06/27/2012CN101967123B 2-cyclopropyl-4-(N-methyl substituted anilino) quinoline compound as well as intermediate, preparation method and application thereof
06/27/2012CN101863831B Method for separating quinoline from coal and biomass coliquified oil product
06/27/2012CN101805287B Method for one-pot liquid phase synthesis of quinoline and derivative thereof
06/27/2012CN101781299B One-pot synthesis method for key intermediate of carbostyril medicaments
06/26/2012US8207345 Antitumor agents; use in combination with other drugs such as pentamidine
06/26/2012US8207343 Process for preparing montelukast and salts thereof
06/26/2012US8207342 Substituted 3-amino-2-mercaptoquinolines as KCNQ2/3 modulators
06/26/2012CA2438582C Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/21/2012WO2012083246A1 Novel n- (4- (azetidine - 1 - carbonyl) phenyl) - (hetero - ) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
06/21/2012WO2012079164A1 Activators of cylindrical proteases
06/21/2012US20120157641 Cure accelerators for anaerobic curable compositions
06/21/2012US20120157493 Antifungal and Antiparasitic Indoloquinoline Derivatives
06/21/2012US20120157447 Quinolone Carboxylic Acids, Derivatives Thereof, and Methods of Making and Using Same
06/21/2012US20120156255 Drug eluting patch for the treatment of localized tissue disease or defect
06/21/2012CA2821975A1 Novel n-(4-(azetidine - 1 - carbonyl)phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
06/21/2012CA2819317A1 Compounds useful for treating aids
06/20/2012EP1960347B1 17-beta-hydroxysteroid dehydrogenase type 3 (17beta-hsd3) inhibitors
06/20/2012EP1910378B1 Hepatitis c inhibitor peptide analogs
06/20/2012CN102510855A Crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quin0lin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide
06/20/2012CN101151248B 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity
06/19/2012US8202885 Bridged six-membered ring compounds
06/19/2012US8202858 Vasopressin V1a antagonists
06/19/2012US8202679 Oxime ester compound and photopolymerization initiator containing the same
06/14/2012WO2012077134A1 Process for preparing aripiprazole polymorphs
06/14/2012WO2012077133A1 Processes for preparation of montelukast sodium and purification of diol intermediate
06/14/2012WO2012077123A1 Purification of montelukast using a simulated moving bed
06/14/2012WO2011072241A9 4-oxo-1h-quinoline-3-carboxamides as modulators of atp-binding cassette transporters
06/14/2012US20120149909 N-substituted-n-phenylethylsulfonamides for the identification of biological and pharmacological activity
06/14/2012US20120149693 Therapeutic compounds
06/13/2012EP2463714A1 Basic compound, chemically amplified resist composition and patterning process
06/13/2012EP2463276A1 Nitrogenous-ring acylguanidine derivative
06/13/2012EP2462117A1 Quinolinyloxyphenylsulfonamides
06/13/2012EP2461683A1 Bicyclic aryl sphingosine 1-phosphate analogs
06/13/2012EP1944291B1 Optically active cyclic alcohol compound and method for producing same
06/13/2012EP1776119B9 Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators
06/13/2012EP1618087B1 Antibacterial agents
06/13/2012CN102498084A Process for production of oxidation reaction product of aromatic compound
06/13/2012CN101792414B Method for preparing 2-(3'-quinolyl) propenol
06/13/2012CN101541753B 2-aminoquinolines as 5-HT(5A) receptor antagonists
06/13/2012CN101406469B Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/12/2012US8198454 Amide derivatives and medicinal use thereof
06/12/2012US8198451 Process for the synthesis of moxifloxacin hydrochloride
06/12/2012US8198450 Quinolinone derivatives and their pharmaceutical compositions
06/12/2012US8198314 Treatment of CRTH2-mediated diseases and conditions
06/12/2012US8198300 Method for preventing tau protein aggregation and treating Alzheimer's disease with a quinoline derivative compound
06/07/2012WO2012075210A2 Method for treating refractory cancer
06/07/2012WO2012073146A1 Kat ii inhibitors
06/07/2012WO2012072489A1 Alpha,beta-unsaturated imines
06/07/2012US20120142931 Purification of montelukast using simulated moving bed
06/07/2012US20120142731 Methods of inhibiting viral infection
06/07/2012US20120142729 KAT ll INHIBITORS
06/07/2012US20120142727 Nitrogenous-ring acylguanidine derivative
06/07/2012US20120142707 Modified c-3 betulinic acid derivatives as hiv maturation inhibitors
06/07/2012US20120142646 Novel Compounds 621
06/07/2012CA2819106A1 Kat ii inhibitors
06/06/2012EP2459529A1 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands
06/06/2012EP1751149B1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
06/06/2012EP1633718B1 COMPOSITIONS AND METHODS FOR INHIBITING TGF-s
06/06/2012CN101747265B Method for preparing 2-cyclopropyl-4-(4'-fluorophenyl) quinoline-3-methanol
06/05/2012US8193361 for plants; 2-(dibenzofuranyl-2-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; 2-(indanyl-5-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; 2-(3-phenylquinolinyl-6-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; phytopathogenic fungi
06/05/2012US8193241 Discodermolide analogues and methods of their use
06/05/2012US8193199 Heterocyclic compounds and their uses
05/2012
05/31/2012WO2012069856A1 Antimalarial compounds
05/31/2012WO2012069683A1 Haptens and immunoreactive agents and use thereof for producing family antibodies and immunoassays for quinolones
05/31/2012US20120136025 Quinolone derivative or pharmaceutically acceptable salt thereof
05/31/2012US20120136018 Quinolines
05/31/2012US20120136002 Protease inhibitors
05/31/2012US20120135249 Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties
05/31/2012CA2815935A1 Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium
05/30/2012EP2456759A2 Pesticidal carboxamides
05/30/2012EP2456440A1 Quinolinone pde2 inhibitors
05/30/2012EP2456435A1 Heteroaryl benzamides, compositions and methods of use
05/30/2012EP2144880B1 Bis(hydroxyquinoline) metal complexes as bleach catalysts
05/30/2012CN102482234A Nitrogen-containing compound and pharmaceutical composition
05/30/2012CN102482221A 作为katii抑制剂的双环和三环化合物 Bicyclic and tricyclic compounds as inhibitors katii
05/30/2012CN102482220A 含氮环酰基胍衍生物 Acyl derivatives of nitrogen-containing cyclic guanidine
05/30/2012CN102477032A 2-cyclopropyl-4-substituted-phenoxy-quinoline derivatives, and its preparation method, intermediate and application
05/30/2012CN101830848B Polyamine derivative as well as preparation method and application thereof
05/30/2012CN101768112B Two-photon induced luminous compound with symmetrical both ends and synthesis method and purposes thereof
05/30/2012CN101691354B Method for chemically synthesizing 2-heteroaryl substituted quinoline derivatives
05/30/2012CN101679392B Quinolone compound and pharmaceutical composition
05/30/2012CN101579344B Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 277